Skip to main content
Clinical Trials/NCT02751086
NCT02751086
Recruiting
N/A

Prospective, Observational, Multicenter Study on Minimally Invasive Gastrectomy for Gastric Cancer: Robotic, Laparoscopic and Open Surgery Compared on Operative and Follow-up Outcomes

International Study Group on Minimally Invasive Surgery for Gastric Cancer1 site in 1 country5,000 target enrollmentApril 2016
ConditionsGastric Cancer

Overview

Phase
N/A
Intervention
Not specified
Conditions
Gastric Cancer
Sponsor
International Study Group on Minimally Invasive Surgery for Gastric Cancer
Enrollment
5000
Locations
1
Primary Endpoint
Rate of patients with intraoperative adverse events
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

The overall purpose is to develop and maintain a multi-institutional database comprising of information regarding surgical, clinical and oncological features of patients that will be treated for gastric cancer with robotic, laparoscopic or open approaches and subsequent follow-up.

The main objective is to compare the three surgical arms on surgical and clinical outcomes, as well as on the oncological follow-up.

Detailed Description

A review of the scientific literature, which was recently published by the IMIGASTRIC study group, aimed to perform a more complete analysis of the current situation regarding performing minimally invasive surgery for gastric cancer. Significant limitations were found in the analyzed studies, including: * Small samples of patients, mostly low-quality comparative studies * Selection bias in the comparison groups (e.g. stage, extent of lymphadenectomy) * Absence of subgroup analysis in significant research fields * Lack of information on the surgical techniques adopted A large prospective multicenter registry could thus be the optimal way to clarify the role of minimally invasive surgery for gastric cancer and permit the evaluation of its short and long-term effects. A working basis for analyzing outcomes of interest and obtaining directions for guidelines and future study developments can also be created. The following would be the main advantages of a large prospective multicenter registry: * Achieving a large sample of patients * Collecting multiple variables, allowing for the making of a comprehensive statistical report * Standardizing the methodology to be adopted, thus increasing accuracy * Bringing together the experiences of both East and West to discover shared points A prospective registry can become a powerful tool that can guide research in this field to new developments and pave the way for other investigational opportunities.

Registry
clinicaltrials.gov
Start Date
April 2016
End Date
December 2024
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
International Study Group on Minimally Invasive Surgery for Gastric Cancer
Responsible Party
Principal Investigator
Principal Investigator

Amilcare Parisi

Principal Investigator

International Study Group on Minimally Invasive Surgery for Gastric Cancer

Eligibility Criteria

Inclusion Criteria

  • Histologically proven gastric cancer
  • Preoperative staging work-up performed by upper endoscopy and/or endoscopic ultrasound, and CT scan and in accordance to international guidelines
  • Early Gastric Cancer
  • Advanced Gastric Cancer
  • Patients treated with curative intent in accordance to international guidelines

Exclusion Criteria

  • Distant metastases: peritoneal carcinomatosis, liver metastases, distant lymph node metastases, Krukenberg tumors, involvement of other organs
  • Patients with high operative risk as defined by the American Society of Anesthesiologists (ASA) score \> 4
  • History of previous abdominal surgery for gastric cancer
  • Synchronous malignancy in other organs
  • Palliative surgery

Outcomes

Primary Outcomes

Rate of patients with intraoperative adverse events

Time Frame: During surgery

events other than the normal course of the surgery

Mean of retrieved lymph nodes

Time Frame: Within 30 days after surgery

Count of retrieved lymph nodes at the histopathological examination of the surgical specimen

Rate of patients alive

Time Frame: 5 year after surgery

subjects alive at the planned endpoint

Secondary Outcomes

  • Mean post-operative hospital stay(from the day after surgery to patient discharge, assessed up to 90 days)
  • Rate of complications after discharge(5 year after surgery)

Study Sites (1)

Loading locations...

Similar Trials